Its a once-weekly shot that works by mimicking your bodys natural hormones, helping you feel fuller faster, and for longer
Saxenda, the first GLP-1 cleared for weight loss treatment, was approved in 2014, but Wegovy, a significantly more effective version, wasnt approved until 2021
It works on two receptors as opposed to one that semaglutide affects
Integration into the treatment, frequency of use and combination with other active ingredients must be defined according to professional assessment
Im not treating it like its in a separate silo. GLP-1s and binge eating disorder Ihlenfeld said GLP-1s are fantastic medications for people with type 2 diabetes, but there is minimal research on how the drug class impacts people with an eating disorder
If cost is your main concern, it may be worth considering